Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Dow Jones Rallies After Surprise Jobless Claims, Retail Sales; Adobe Dives On Earnings

The Dow Jones rallied Thursday after a surprise drop in initial unemployment claims and U.S. retail sales. Adobe stock dived on earnings.

Investors Business Daily

Dow Jones Falls After Cool Inflation Data; Tesla Slides On Recall; Fed Decision, Powell Up Next

The Dow Jones fell after more key inflation data Wednesday. The Fed's interest rate decision and Powell's comments are later in the day.

Investors Business Daily

Dow Jones Reverses On CPI Inflation Report; Tech Giant Oracle Dives On Earnings

The Dow Jones reversed higher Tuesday on the Consumer Price Index inflation report. Tech giant Oracle dived on weak sales results.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

The Independent UK

Dow Jones Futures: Magnificent Seven Stocks Slide; AI Giant Oracle Dives On Earnings; CPI Next

Dow Jones futures: The Magnificent Seven stocks tumbled Monday, with heavy losses in Nvidia and Tesla. The CPI inflation report is next.

Investors Business Daily

Eli Lilly Stock Skids On A Key New Finding For Its Obesity Drug, Zepbound

Eli Lilly stock skidded Monday after a new study showed patients who stopped taking its weight-loss drug slowly regained weight over a year.

Investors Business Daily

Dow Jones Falls; Apple Headlines 9 Best Stocks To Buy And Watch

The Dow Jones fell Monday ahead of this week's CPI and Fed meeting. Apple stock headlines 9 best stocks to buy and watch.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Reverses Higher On Strong Jobs Report; LULU Stock Rallies On Earnings

The Dow Jones Industrial Average reversed Friday on a stronger-than-expected November jobs report. LULU stock rallied on earnings.

Investors Business Daily

Dow Jones Climbs After Jobless Claims Rise; Google Stock Surges After Gemini AI Model

The Dow Jones climbed Thursday after the Labor Department's jobless claims. Google stock surged after unveiling its Gemini AI model.

Investors Business Daily

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

Inverse

Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal

Amphastar is IBD Stock Of The Day as the biotech stock revs up marketing of Baqsimi, a drug purchased this year from Eli Lilly.

Investors Business Daily

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

International Business Times

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK

Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review

The Dow Jones pushed higher, but the Nasdaq slipped despite strong software earnings and a Fed shift toward rate cuts. Tesla Cybertruck deliveries began.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

December Looks Great For Investors Who Own 9 Stocks

Investors can only hope stocks do as well in December as they did in November. There are definitely some S&P 500 stocks that glisten.

Fortune

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

Zepbound is expected to be available in the U.S. by the end of the year.

Investors Business Daily

Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives

Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study.

Investors Business Daily

Google Leads Five S&P 500 Stocks Near Buy Points

Google leads this watchlist of five S&P 500 stocks near buy points as the market rally has investors seeing green.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly Stock Nears Another Record As Drugmaker Enters The Weight-Loss Arena

Eli Lilly stock is Monday's IBD Stock Of The Day. Shares are forming a new flat base after the FDA approved Lilly's new weight-loss drug.

Barchart

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Investors Business Daily

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

Investors Business Daily

This Option Trade On Eli Lilly Stock Could Return 27% By Mid-January

This iron condor trade on Eli Lilly stock has the potential to return 27% if the stock price stays between about 510 and 680.

Investors Business Daily

Novo Nordisk Stock Skids — But These Weight-Loss Results Are 'Hard To Ignore'

Novo Nordisk stock slumped Monday despite unveiling promising test results for weight-loss drugs and diabetes development.

Investors Business Daily

Top Funds Can't Get Enough Of Amazon — And This Intelligence Play

As a Santa Claus rally begins, the AI boom continues to fuel gains for Palantir and Amazon as top funds place their bets.

Investors Business Daily

Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review

The stock market rally erased weekly gains as the major indexes ended long win streaks amid rebounding yields. Datadog led earnings winners.

1 … 15 16 17 18

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.